Skip to main content

Self-Reported Post-COVID Symptoms at 18 Months After Infection Among Adults in Southern Brazil: A Cross-Sectional Study

Publication ,  Journal Article
de Brito, FAM; Laranjeira, C; Moroskoski, M; Salci, MA; Rossoni, SL; Baccon, WC; de Oliveira, RR; Marques, PG; de Freitas Góes, HL; Mello, FF ...
Published in: Healthcare Switzerland
February 1, 2025

Background/Objectives: Currently, there is a limited understanding of the long-term consequences following acute COVID-19, referred to as long COVID. This cross-sectional study aims to analyze the prevalence of persistent signs and symptoms of long COVID, 18 months after primary SARS-CoV-2 infection in adults in southern Brazil. Methods: Using two national databases (the digital registry of SARS-CoV-2 positive cases), 370 individuals living in the state of Paraná (Brazil) were recruited. Data were collected through telephone interviews conducted in 2021 and 2022. Results: The overall prevalence of long COVID was 66.2% among study participants. During the acute phase of infection, the most common symptom clusters included neurological symptoms (87.0%; n = 318), followed by respiratory (82.0%; n = 301), musculoskeletal (66.0%; n = 241), digestive (50.0%; n = 184), psychological (38.0%; n = 138), and endocrine symptoms (28.0%; n = 104). In the 18 month follow-up, the main persistent symptoms were memory loss (42.7%), fatigue (32.2%), anxiety (23.5%), dyspnea (19.7%), and hair loss (19.7%). The proportion of participants with long COVID was statistically higher in females (73.9%), those with a family income below two minimum wages (94.7%), those who do not practice physical activity (83.3%), those who report poor sleep quality (93.3%), those who use long-term medication (85.9%), those who needed health care in the previous six months (87.3%), those who required professional and/or family care (79.3%), those who were in the ICU (79.0%), and those who used ventilatory support (77.5%). Conclusions: Long COVID is a complex condition that requires long-term monitoring and investment in health services due to its high prevalence and the health consequences in the population.

Duke Scholars

Published In

Healthcare Switzerland

DOI

EISSN

2227-9032

Publication Date

February 1, 2025

Volume

13

Issue

3

Related Subject Headings

  • 42 Health sciences
  • 32 Biomedical and clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
de Brito, F. A. M., Laranjeira, C., Moroskoski, M., Salci, M. A., Rossoni, S. L., Baccon, W. C., … Carreira, L. (2025). Self-Reported Post-COVID Symptoms at 18 Months After Infection Among Adults in Southern Brazil: A Cross-Sectional Study. Healthcare Switzerland, 13(3). https://doi.org/10.3390/healthcare13030228
Brito, F. A. M. de, C. Laranjeira, M. Moroskoski, M. A. Salci, S. L. Rossoni, W. C. Baccon, R. R. de Oliveira, et al. “Self-Reported Post-COVID Symptoms at 18 Months After Infection Among Adults in Southern Brazil: A Cross-Sectional Study.” Healthcare Switzerland 13, no. 3 (February 1, 2025). https://doi.org/10.3390/healthcare13030228.
de Brito FAM, Laranjeira C, Moroskoski M, Salci MA, Rossoni SL, Baccon WC, et al. Self-Reported Post-COVID Symptoms at 18 Months After Infection Among Adults in Southern Brazil: A Cross-Sectional Study. Healthcare Switzerland. 2025 Feb 1;13(3).
de Brito, F. A. M., et al. “Self-Reported Post-COVID Symptoms at 18 Months After Infection Among Adults in Southern Brazil: A Cross-Sectional Study.” Healthcare Switzerland, vol. 13, no. 3, Feb. 2025. Scopus, doi:10.3390/healthcare13030228.
de Brito FAM, Laranjeira C, Moroskoski M, Salci MA, Rossoni SL, Baccon WC, de Oliveira RR, Marques PG, de Freitas Góes HL, Mello FF, da Cruz Blaszczak FRB, Vissoci JRN, Puente Alcaraz J, Facchini LA, Carreira L. Self-Reported Post-COVID Symptoms at 18 Months After Infection Among Adults in Southern Brazil: A Cross-Sectional Study. Healthcare Switzerland. 2025 Feb 1;13(3).

Published In

Healthcare Switzerland

DOI

EISSN

2227-9032

Publication Date

February 1, 2025

Volume

13

Issue

3

Related Subject Headings

  • 42 Health sciences
  • 32 Biomedical and clinical sciences